Karsten Meisloch

Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA.

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

Allied Domecq Ltd. operates distilleries and restaurants. It offers wine, liquors, brandies spirits, and quick service restaurants. The firm's products are sold under the Ballantine's, Beefeater, Canadian Club, Courvoisier, Kahlua, Maker's Mark, Malibu, Sauza and Stolichnaya brands. The company was founded in 1961 and is headquartered in London, the United Kingdom.

Bacardi & Co. Ltd. engages in the production and distribution of alcoholic beverages. It offers products that include rum, wine, whisky, tequila, vodka, cocktail mixes and distilled spirits. The firm is a subsidiary of Bacardi Ltd. The company is headquartered in Nassau, Bahamas.

SARcode Bioscience, Inc., develops biopharmaceutical products. Its program is a novel class of lymphocyte function-associated antigen-1 (LFA-1) antagonists for the treatment T-cell mediated inflammatory diseases. The company was founded by Thomas Gadek and John P. Burnier in 2006 and is headquartered in Brisbane, CA.

3i Deutschland Gesellschaft für Industriebeteiligungen mbH (3i Deutschland) is the German private equity subsidiary of 3i Group Plc (LSE: III) in Great Britain. Established in Frankfurt in 1984, the firm invests in small and medium-sized German companies at all stages of development, from start-ups to established businesses. In addition to the Frankfurt office, 3i Deutschland has offices in Munich and Stuttgart. They drive their investment focus and decisions from their Frankfurt and Munich offices, and the team collaborates with Swiss colleagues in Zurich and 3i's network across Europe, Asia and the U.S. to invest in a wide range of industry sectors.

Slaughter & May Ltd. provides legal services. It provides services in such practice areas as mergers and acquisitions, financial regulation, intellectual property, information technology, pensions, employment and real estate. The company was founded by William Capel Slaughter and William May on January 1, 1889 and is headquartered in London, the United Kingdom.

GlycoFi, Inc. develops biopharmaceutical products. It provides protein production technology to develop, produce and commercialize biotherapeutics products. The company was founded by Tillman Gerngross in 2000 and is headquartered in Lebanon, NH.

Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany.

CellCarta Biosciences, Inc. develops proteomics and immune monitoring services. The firm offers integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Its services include biomarker discovery, cell engine software, cellular enumeration, clinical laboratory services, functional profiling, host cell proteins detection, phenotyping characterization and receptor occupancy. The company was founded by Martin LeBlanc in 2000 and is headquartered in Montréal, Canada.

Emperra GmbH E-Health Technologies manufactures and designs telemedicine technologies. The firm specializes in the development of medical monitoring devices for the tracking and transmission of diabetic patients' diagnostic and therapeutic data. It develops components and systems under the ESYSTA product brand, featuring data acquisition, analysis, and transfer solutions. The company was founded by Janko Schildt in 2008 and is headquartered in Potsdam, Germany.

SuppreMol GmbH engages in the development and use of active substances for the therapy of autoimmune diseases and allergies, as well as the research on and development of medicinal products. It also produces medicines through licensed manufacturers. The products are supplied via pharmaceutical wholesale. The company was founded by Robert Huber, Uwe Jacob, and Peter Sondermann in 2002 and is headquartered in Berlin, Germany.

Part of Takeda Pharmaceutical Co., Ltd., Shire Deutschland Investments GmbH develops and markets pharmaceutical products. The company is based in Berlin, Germany. The CEOs of the German company are Roland Kurney, Heidrun Irschik-Hadjieff.

Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland.

Peppermint VenturePartners GmbH (PVP) is an independent venture capital firm founded in 2008 by Ingeborg Neumann, Dr. Joachim Rautter, and Dr. Klaus Stöckemann. It is headquartered in Berlin, Germany.

Humedics GmbH operates as a research-based medtech company. It focuses on rapid and precise lover function measurement using LiMax, a breath analysis technology. The company was founded by Martin Stockman, Erwin de Bujizer, and Karsten Heyne in 2009 and is headquartered in Berlin, Germany.

Implandata Ophthalmic Products GmbH develops diagnosis tool for glaucoma therapy. Its technology Pro-IOP is an eye pressure measurement system consists of an implantable micro sensor, responsible for pressure sensing, an external hand held device, which is transferring energy to the micro sensor telemetrically and which is responsible for data read out and storage and a GSM module which can be connected with the hand held device for transfer of measurement data to a database, which can be accessed by the eye doctor in order to get information about the disease status of the patient. The company was founded by Max Georg Ostermeier and Stefan Meyer in January 2010 and is headquartered in Hannover, Germany.

Stallergenes GmbH prepares and provides pharmaceuticals for the treatment of allergies. The firm's products range from diagnostic to allergen immunotherapy. It develops allergen immunotherapy and allergen supplied with highly innovative and individually tailored solutions. The company is headquartered in Kamp-Lintfort, Germany.

The National Youth Orchestra of Great Britain is an inclusive and diverse community of committed teenage musicians who aspire to share their love for orchestral music and their passion for peer-learning opportunities. The non-profit company is based in Great Britain. Experience their youthful energy at a concert hall near you or apply to become a member of NYO.

TearSolutions, Inc. develops natural tear generation therapy for dry eyes. The firm's platform technology focuses on the tear protein 'lacritin'? and the proprietary drug 'Lacripep'?. The company was founded by Mark B. Logan, and Gordon W. Laurie in 2013 and is headquartered in Charlottesville, VA.

EIP Pharma, Inc. engages in the research and development of therapeutic drugs for the central nervous system disorders. It focuses on neflamapimod, which is a clinical-stage oral investigational drug for the treatment of brain diseases such as Alzheimer?s disease and for non-brain disorders including rheumatoid arthritis. The company was founded by John Alam and Sylvie Louise Gregorie and is headquartered in Cambridge, MA.

Part of Takeda Pharmaceutical Co., Ltd., Takeda Pharma Vertrieb GmbH & Co. KG is a German company that sells pharmaceutical products. The company is based in Berlin, Germany. The CEOs are Roland Kurney, Heidrun Irschik-Hadjieff. The company was founded in 1781.

Rogne Bioscience, Inc. is an American company that focuses on researching and developing biotechnology products. The private company is based in Portola Valley.